Emmanuel Srofenyoh
Research Subjects
Emmanuel Srofenyoh has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
Kwame Adu-Bonsaffoh
Department of Obstetrics and Gynecology, School of Medical Sciences, University of Ghana, Legon, Greater Accra, Ghana
2 shared publicationsAbena Odurowaa Yeboah
Greater Accra Regional Hospital, Ghana Health Service, Accra, Ghana
1 shared publication- Adeyemi Olufolabi
Department of Anesthesiology, Duke University Medical Center, Durham, NC, USA
1 shared publication Cyril Engmann
University of North Carolina, Chapel Hill, North Carolina, USA
1 shared publication- Daniel Arhinful
Noguchi Memorial Institute for Medical Research, University of Ghana, Accra, Ghana
1 shared publication - Elom Hillary Otchi
Graduate School of Healthcare Management, Royal College of Surgeons Ireland , Ireland+353, Dublin
1 shared publication
Latest Publications
- Open Access
Predictive accuracy of ophthalmic artery Doppler for pre-eclampsia: a systematic review
Objectives: This systematic review investigated available evidence on the stand-alone and incremental predictive performance of ophthalmic artery Doppler (OAD) for pre-eclampsia. Design: Systematic review. Data sources: We conducted a literature search from PubMed (Medline), the Cochrane CENTRAL, EMBASE and Scopus from inception to 8 April 2025. Eligibility criteria: Studies eligible for inclusion were prospective or retrospective cohort studies, case-control studies or randomised controlled trials that reported on the predictive performance of OAD for pre-eclampsia in singleton pregnancies; and conducted in either high-income country (HIC) or low- and middle-income country (LMIC). Data extraction and synthesis: Two reviewers independently screened and assessed articles for inclusion. One reviewer then extracted data using a standardised data extraction sheet, and any uncertainties were discussed with a second reviewer. The Prediction model Risk of Bias Assessment Tool was used for quality and risk of bias assessment. Findings were summarised and reported according to the Preferred Reporting Items for Systematic Review and Meta-Analyses statement and synthesised qualitatively. Results: We identified and included 11 observational studies (3 from HIC and 8 from LMICs) with a total of 12 150 singleton pregnancies, of which 517 (4.3%) were complicated by pre-eclampsia at end of follow-up. The included studies were of varied quality, with three at low risk of bias, four at unclear risk and four at high risk. No interventional study was identified. Three studies (27.3%) recruited high-risk pregnancies (defined according to the American College of Obstetricians and Gynecologists (ACOG) criteria as one or more of the following: chronic hypertension, personal or family history of pre-eclampsia, early (≤18 years) or late (≥40 years) first pregnancy, primipaternity, chronic kidney disease, increased body mass index >30 kg/m 2 , presence of diabetes mellitus prior to pregnancy, autoimmune disease and thrombophilia), while eight studies (72.7%) recruited undetermined risk pregnancies. Stand-alone performance of OAD (interpreted by area under the receiver operating curve at 95% CI) showed that in the first trimester, the peak systolic velocity (PSV) ratio demonstrated very good predictive ability (0.97, 95% CI 0.92 to 1.0) (n=1 study), and the second PSV (PSV 2 ) demonstrated very good predictive ability (0.91, 95% CI 0.82 to 0.99) (n=1 study). Also, PSV 2 demonstrated fair predictive ability (0.61, 95% CI 0.42 to 0.79; and 0.53, 95% CI 0.40 to 0.66) for early and late pre-eclampsia, respectively (n=1 study). In the second trimester, the PSV ratio demonstrated very good predictive ability (0.88, 95% CI 0.84 to 0.91) (n=1 study), and PSV 2 demonstrated good predictive ability (0.73, 95% CI 0.66 to 0.81; and 0.76, 95% CI 0.71 to 0.81) for pre-eclampsia (n=2 studies). In the third trimester, the PSV ratio demonstrated good predictive ability (0.82, 95% CI 0.73 to 0.89; and 0.77, 95% CI 0.71 to 0.82) for preterm and term pre-eclampsia, respectively (n=1 study). Also, PSV 2 demonstrated good predictive ability 0.70 (0.57 to 0.84) (n=1 study). Subsequently, in the second trimester, PSV ratio demonstrated better incremental predictive performance than uterine artery pulsatility index for preterm pre-eclampsia, when added to maternal factors and mean arterial pressure (MAP) (56.1%–80.2% vs 56.1%–74.8% detection rate (DR) at 10% FPR) (n=1 study). Also in the third trimester, adding PSV ratio to maternal factors and MAP was superior to soluble fms-like tyrosine kinase-1/placental growth factor ratio in predicting pre-eclampsia at 2 are potentially useful ultrasound markers for pre-eclampsia prediction. Particularly in the second trimester, adding PSV ratio to maternal factors and MAP significantly improved the prediction of preterm pre-eclampsia. Given the burden of early and preterm pre-eclampsia in low-resource settings, OAD appears promising for pre-eclampsia screening in these settings where serum biomarkers may be expensive and inaccessible, and where uterine artery Doppler may not be technically feasible. However, the extent to which this novel marker is implemented in routine antenatal care should be guided by larger and sufficiently powered validation studies. PROSPERO registration number: CRD42022324569.
Open AccessPredictive accuracy of ophthalmic artery Doppler for pre-eclampsia: a systematic review
Objectives: This systematic review investigated available evidence on the stand-alone and incremental predictive performance of ophthalmic artery Doppler (OAD) for pre-eclampsia. Design: Systematic review. Data sources: We conducted a literature search from PubMed (Medline), the Cochrane CENTRAL, EMBASE and Scopus from inception to 8 April 2025. Eligibility criteria: Studies eligible for inclusion were prospective or retrospective cohort studies, case-control studies or randomised controlled trials that reported on the predictive performance of OAD for pre-eclampsia in singleton pregnancies; and conducted in either high-income country (HIC) or low- and middle-income country (LMIC). Data extraction and synthesis: Two reviewers independently screened and assessed articles for inclusion. One reviewer then extracted data using a standardised data extraction sheet, and any uncertainties were discussed with a second reviewer. The Prediction model Risk of Bias Assessment Tool was used for quality and risk of bias assessment. Findings were summarised and reported according to the Preferred Reporting Items for Systematic Review and Meta-Analyses statement and synthesised qualitatively. Results: We identified and included 11 observational studies (3 from HIC and 8 from LMICs) with a total of 12 150 singleton pregnancies, of which 517 (4.3%) were complicated by pre-eclampsia at end of follow-up. The included studies were of varied quality, with three at low risk of bias, four at unclear risk and four at high risk. No interventional study was identified. Three studies (27.3%) recruited high-risk pregnancies (defined according to the American College of Obstetricians and Gynecologists (ACOG) criteria as one or more of the following: chronic hypertension, personal or family history of pre-eclampsia, early (≤18 years) or late (≥40 years) first pregnancy, primipaternity, chronic kidney disease, increased body mass index >30 kg/m 2 , presence of diabetes mellitus prior to pregnancy, autoimmune disease and thrombophilia), while eight studies (72.7%) recruited undetermined risk pregnancies. Stand-alone performance of OAD (interpreted by area under the receiver operating curve at 95% CI) showed that in the first trimester, the peak systolic velocity (PSV) ratio demonstrated very good predictive ability (0.97, 95% CI 0.92 to 1.0) (n=1 study), and the second PSV (PSV 2 ) demonstrated very good predictive ability (0.91, 95% CI 0.82 to 0.99) (n=1 study). Also, PSV 2 demonstrated fair predictive ability (0.61, 95% CI 0.42 to 0.79; and 0.53, 95% CI 0.40 to 0.66) for early and late pre-eclampsia, respectively (n=1 study). In the second trimester, the PSV ratio demonstrated very good predictive ability (0.88, 95% CI 0.84 to 0.91) (n=1 study), and PSV 2 demonstrated good predictive ability (0.73, 95% CI 0.66 to 0.81; and 0.76, 95% CI 0.71 to 0.81) for pre-eclampsia (n=2 studies). In the third trimester, the PSV ratio demonstrated good predictive ability (0.82, 95% CI 0.73 to 0.89; and 0.77, 95% CI 0.71 to 0.82) for preterm and term pre-eclampsia, respectively (n=1 study). Also, PSV 2 demonstrated good predictive ability 0.70 (0.57 to 0.84) (n=1 study). Subsequently, in the second trimester, PSV ratio demonstrated better incremental predictive performance than uterine artery pulsatility index for preterm pre-eclampsia, when added to maternal factors and mean arterial pressure (MAP) (56.1%–80.2% vs 56.1%–74.8% detection rate (DR) at 10% FPR) (n=1 study). Also in the third trimester, adding PSV ratio to maternal factors and MAP was superior to soluble fms-like tyrosine kinase-1/placental growth factor ratio in predicting pre-eclampsia at 2 are potentially useful ultrasound markers for pre-eclampsia prediction. Particularly in the second trimester, adding PSV ratio to maternal factors and MAP significantly improved the prediction of preterm pre-eclampsia. Given the burden of early and preterm pre-eclampsia in low-resource settings, OAD appears promising for pre-eclampsia screening in these settings where serum biomarkers may be expensive and inaccessible, and where uterine artery Doppler may not be technically feasible. However, the extent to which this novel marker is implemented in routine antenatal care should be guided by larger and sufficiently powered validation studies. PROSPERO registration number: CRD42022324569.
- Open Access
User perspectives, challenges and opportunities in the implementation of protein-to-creatinine dipstick test for proteinuria detection in Ghana: a mixed methods study
Objective To assess the appropriateness, acceptability and feasibility of implementing the Test-it PrCr Urinalysis Dipstick Test (LifeAssay Diagnostics, South Africa) in referral hospitals in Ghana. Participants 96 healthcare professionals were trained on the protein-to-creatinine (PrCr) test, which was integrated into protocols alongside standard-of-care tests between November 2021 and April 2022. Test users completed questionnaires post training. Three focus group discussions (FGDs) and seven key informant interviews were conducted to evaluate test procedure comprehension, insights into training effectiveness, usability/user confidence, perceptions, attitudes towards the test and barriers and facilitators of use. Results High product usability, user confidence and satisfaction were reported. Staff perceived the test as easy to use and similar to current products. Misinterpretations of test results were less likely for strong results. Facilitators of use included effective trainings, sensitisation of the product and key stakeholder endorsement. Challenges impacting implementation feasibility included the short shelf life of test strips (3 months) after opening cannisters, the added complexity of the ratiometric result interpretation and the test’s lack of other parameters that are included in current products (eg, glucose, nitrate), limiting its broader clinical utility for antenatal care screening. All FGD participants agreed that the use of the PrCr test would not change current practices/protocols for dipstick use. Conclusion Although the Test-It PrCr test is easy to use and well accepted, key product attributes limit its implementation feasibility in this setting. It may be more appropriate for monitoring high-risk women in this context.
Open AccessUser perspectives, challenges and opportunities in the implementation of protein-to-creatinine dipstick test for proteinuria detection in Ghana: a mixed methods study
Objective To assess the appropriateness, acceptability and feasibility of implementing the Test-it PrCr Urinalysis Dipstick Test (LifeAssay Diagnostics, South Africa) in referral hospitals in Ghana. Participants 96 healthcare professionals were trained on the protein-to-creatinine (PrCr) test, which was integrated into protocols alongside standard-of-care tests between November 2021 and April 2022. Test users completed questionnaires post training. Three focus group discussions (FGDs) and seven key informant interviews were conducted to evaluate test procedure comprehension, insights into training effectiveness, usability/user confidence, perceptions, attitudes towards the test and barriers and facilitators of use. Results High product usability, user confidence and satisfaction were reported. Staff perceived the test as easy to use and similar to current products. Misinterpretations of test results were less likely for strong results. Facilitators of use included effective trainings, sensitisation of the product and key stakeholder endorsement. Challenges impacting implementation feasibility included the short shelf life of test strips (3 months) after opening cannisters, the added complexity of the ratiometric result interpretation and the test’s lack of other parameters that are included in current products (eg, glucose, nitrate), limiting its broader clinical utility for antenatal care screening. All FGD participants agreed that the use of the PrCr test would not change current practices/protocols for dipstick use. Conclusion Although the Test-It PrCr test is easy to use and well accepted, key product attributes limit its implementation feasibility in this setting. It may be more appropriate for monitoring high-risk women in this context.
- Open Access
- 11 April 2022
- Published by Oxford University Press (OUP) in IJQHC Communications
- Vol. 2 (1)
Improving ‘needless’ waits in an obstetric ER: implementing an obstetric triage system in a tertiary hospital in Ghana
Background: Maternal mortality is the bane of obstetric practice in sub-Saharan Africa. The delay in receiving care upon arrival in a hospital is a significant contributor to maternal mortalities. Obstetric triaging allows the prioritization of care based on patient acuity. This allows orderly access to care and reduces delays in the health facility. Methods: This study was a quality improvement project that set out to establish an obstetric triaging system in the Department of Obstetrics and Gynaecology of the Korle Bu Teaching Hospital (KBTH) starting in December 2016, and assess its impact primarily on the pre-implementation waiting time of 4.2 h, 1 year on after implementation. The project was scheduled in phases which included training, development of an Obstetric Emergency System, development of process maps, and reorganization of care, infrastructural works all culminating in the establishment of a Triage System. Results: Results from data collected 1 year on showed an average reduction in waiting time from 4.2 h (252 min) to an average of 138.8 min. Conclusions: Triaging has helped to improve the timeliness and has added a patient-centered approach to care offered in the Obstetric Emergency of the Korle Bu Teaching Hospital.
- 11 April 2022
- Published by Oxford University Press (OUP) in IJQHC Communications
- Vol. 2 (1)
Open AccessImproving ‘needless’ waits in an obstetric ER: implementing an obstetric triage system in a tertiary hospital in Ghana
Background: Maternal mortality is the bane of obstetric practice in sub-Saharan Africa. The delay in receiving care upon arrival in a hospital is a significant contributor to maternal mortalities. Obstetric triaging allows the prioritization of care based on patient acuity. This allows orderly access to care and reduces delays in the health facility. Methods: This study was a quality improvement project that set out to establish an obstetric triaging system in the Department of Obstetrics and Gynaecology of the Korle Bu Teaching Hospital (KBTH) starting in December 2016, and assess its impact primarily on the pre-implementation waiting time of 4.2 h, 1 year on after implementation. The project was scheduled in phases which included training, development of an Obstetric Emergency System, development of process maps, and reorganization of care, infrastructural works all culminating in the establishment of a Triage System. Results: Results from data collected 1 year on showed an average reduction in waiting time from 4.2 h (252 min) to an average of 138.8 min. Conclusions: Triaging has helped to improve the timeliness and has added a patient-centered approach to care offered in the Obstetric Emergency of the Korle Bu Teaching Hospital.
- 1 January 2010
- Published by Wolters Kluwer Health in International Anesthesiology Clinics
- Vol. 48 (2) , 109-122
Multidisciplinary Team Partnerships to Improve Maternal and Neonatal Outcomes
- 1 January 2010
- Published by Wolters Kluwer Health in International Anesthesiology Clinics
- Vol. 48 (2) , 109-122
Multidisciplinary Team Partnerships to Improve Maternal and Neonatal Outcomes